The rising incidence of chronic renal failures is anticipated to create lucrative growth opportunities for the global Dialyzer market, finds Fortune Business Insights in their new study. The study is titled, “Dialyzer Market: Global Market Analysis, Insights, and Forecasts, 2019 – 2026.” According to the study, the market will rise at a CAGR of 4.9% and reach a value of US$ 13707.2 Mn by the end of 2026 as against US$ 9344.7 Mn in 2019.
For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/Dialyzer-market-100166
Launch of Dicap Pro Hemodialyzer by Baxter to Intensify Market Competition
The global market is expected to gain more revenue from Asia Pacific owing to the rise in number of end stage renal disease patients in developing countries of China, and India. In 2018, the market in Asia Pacific was valued at US$ 3353.9 Mn. This is because of the rapid development in healthcare infrastructure and increasing dialysis system installations across the region.
With the advent of internet of things in healthcare sector, manufacturers are focusing on using IoT for keeping live record of the patient’s health while ongoing dialysis. Governments are also taking initiatives and helping market players come up with better facilities for hemodialysis treatment, thus propelling growth. In 2017, Baxter launched Dicap Pro hemodialyzer, a product designed for enhancing kidney dialysis for patients suffering from chronic kidney disorders. Some of the players operating in the global Dialyzer market are
- Toray Medical Co. Ltd.,
- Asahi Kasei Corporation,
- Nipro Corporation,
- Fresenius Medical Care,
- JMS Co. Ltd.,
- Nikkiso Co., Ltd.,
- B Braun Melsungen.
Request a Sample Copy of the Global Dialyzer Market Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/Dialyzer-market-100166
By Flux Type
By Usage Type
By End User
- Dialysis Centers and Hospitals
- Home Healthcare
More Trending Topics From Fortune Business [email protected]